Discuss This Drug

Mosunetuzumab

CHEBI:CHEBI_748687

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
marketing_start_date
20220302
package_marketing_start_date
02-MAR-22
dosage_form
CONCENTRATE
route
INTRAVENOUS
active_ingredient_strength
60 mg/.001L
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Genentech, Inc.
generic_name
Mosunetuzumab
brand_name
Lunsumio
brand_name_base
Lunsumio
product_ndc
50242-243
application_number
BLA761263
spl_id
8230be3b-c36c-42be-b8b7-b43b9cc030df
active_ingredient_name
MOSUNETUZUMAB
package_ndc
50242-243-06
package_description
6 L in 1 BAG (50242-243-06)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class